InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Einhorn Andrew J., 首席财务官. Insider active across 4 companies, notably Osmotica Pharmaceuticals plc. Cumulatively, 3 reports have been recorded. Activity tracked since 18 May 2021. The latest transaction was filed on 24 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Einhorn Andrew J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
12,000 股Common StockSEC:0001753926-25-001991:0
9,607 股@ US$1.13100.0% 占其流量Ordinary SharesSEC:0001104659-22-007844:0
6,467 股@ US$3.12100.0% 占其流量Ordinary SharesSEC:0001104659-21-069879:0
3 条申报中的 3 条
About Einhorn Andrew J.
Andrew J. Einhorn is the Chief Financial Officer at Osmotica Pharmaceuticals plc and RVL Pharmaceuticals plc. He oversees the financial management of the companies, ensuring compliance and efficiency in financial operations.
